B of A Securities analyst Tim Anderson reinstates Moderna (NASDAQ:MRNA) with a Underperform and announces $41 price target.
- Headlines
- B of A Securities Reinstates Underperform on Moderna, Announces $41 Price Target
B of A Securities Reinstates Underperform on Moderna, Announces $41 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Price
Unlock the Full List
Latest
11:28
Shenzhen synchronously issued restrictions on National III diesel trucks and subsidy policies, with a maximum early retirement subsidy of 0.023 million yuan.
11:26
Hong Kong stock Dining shares performed poorly as a whole, with Helen's falling over 5%, XIABUXIABU dropping 4.4%, HAIDILAO and Naixue's Tea declining over 3%, and JIUMAOJIU and HAITONG INT'L both falling over 2%.
HELENS-5.66%
11:25
The first asset-backed securities product containing copyrights for games and animation in the country has been listed.